AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35031139 — intervention group
Group type: COMPARATOR
Intervention: Systematic sampling (SS)
Number of subjects: 38
Study 33547330 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant exemestane for 5 years
Number of subjects: 807
Study 36064672 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi-DT + MMR
Number of subjects: 360
Study 36064672 — intervention group
Group type: COMPARATOR
Intervention: MMR alone
Number of subjects: 360
Study 34152632 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoadsorption (HA) therapy
Number of subjects: 20
Study 34152632 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 35192543 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCov-19 (AZD1222) vaccination
Number of subjects: 54
Study 33932814 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep-based intervention
Number of subjects: 165
Study 32858523 — intervention group
Group type: EXPERIMENTAL
Intervention: After-school intervention (structured physical activity and academic enrichment activities for 2.5 hours, 3 afternoons per week for 6 months)
Number of subjects: 60
Study 32858523 — intervention group
Group type: COMPARATOR
Intervention: Control (usual after-school care practice)
Number of subjects: 60
Study 36263928 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 343
Study 36263928 — intervention group
Group type: COMPARATOR
Intervention: Insulin degludec 100 U/mL (IDeg-100)
Number of subjects: 343
Study 36263928 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300) and Insulin degludec 100 U/mL (IDeg-100)
Number of subjects: 343
Study 34519665 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention (digitally delivered via a smartphone app)
Number of subjects: 109
Study 34519665 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard multidisciplinary care)
Number of subjects: 109
Study 34519665 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth intervention
Number of subjects: 109
Study 35417762 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional plus Fluciclovine (18F) PET (arm 2)
Number of subjects: 165
Study 35417762 — intervention group
Group type: COMPARATOR
Intervention: Conventional only (arm 1)
Number of subjects: 165
Study 33278503 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose whole-lung irradiation (LD-WLI) 0.5 Gy
Number of subjects: 10
Study 33278503 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose whole-lung irradiation (LD-WLI) 1.0 Gy
Number of subjects: 10
Study 33278503 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose whole-lung irradiation (LD-WLI) overall
Number of subjects: 10
Study 35105383 — intervention group
Group type: EXPERIMENTAL
Intervention: Settled accommodation (Private Rented Sector, Social Housing, Housing First)
Number of subjects: 150
Study 35105383 — intervention group
Group type: COMPARATOR
Intervention: Temporary accommodation (control group)
Number of subjects: 150
Study 33465795 — intervention group
Group type: EXPERIMENTAL
Intervention: Melissa Officinalis L. (500 mg daily)
Number of subjects: 60
Study 33465795 — intervention group
Group type: COMPARATOR
Intervention: Citalopram (30 mg)
Number of subjects: 60
Study 33465795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32164522 — intervention group
Group type: EXPERIMENTAL
Intervention: Choline supplementation
Number of subjects: 31
Study 32164522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 36121830 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic medication review conducted by pharmacists during the emergency department stay
Number of subjects: 789
Study 36121830 — intervention group
Group type: COMPARATOR
Intervention: Standard care from emergency department physicians and nurses
Number of subjects: 789
Study 34893523 — intervention group
Group type: EXPERIMENTAL
Intervention: Andecaliximab (ADX) plus Nivolumab (NIVO)
Number of subjects: 144
Study 34893523 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab (NIVO) alone
Number of subjects: 144
Study 33579359 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid micro-induction of buprenorphine/naloxone
Number of subjects: 50
Study 33579359 — intervention group
Group type: COMPARATOR
Intervention: Standard induction of buprenorphine/naloxone
Number of subjects: 50
Study 36396490 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat occlusal scheme with feather-edge finish line (FF)
Number of subjects: 66
Study 36396490 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat occlusal scheme with rounded shoulder finish line (FS)
Number of subjects: 66
Study 36396490 — intervention group
Group type: COMPARATOR
Intervention: Planar occlusal scheme with rounded shoulder finish line (PS)
Number of subjects: 66
Study 35278124 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg etifoxine
Number of subjects: 60
Study 35278124 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg alprazolam
Number of subjects: 60
Study 35278124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32663382 — intervention group
Group type: EXPERIMENTAL
Intervention: Online self-help program (Hands-off)
Number of subjects: 242
Study 35760153 — intervention group
Group type: EXPERIMENTAL
Intervention: a‐tDCS
Number of subjects: 40
Study 35760153 — intervention group
Group type: COMPARATOR
Intervention: SHAM
Number of subjects: 40
Study 33624122 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) provided by primary care nurses (n = 50)
Number of subjects: 240
Study 33624122 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) provided by urogynaecology nurse specialist (n = 53)
Number of subjects: 240
Study 33624122 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 240
Study 33624122 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between primary care nurse and urogynaecology nurse specialist groups
Number of subjects: 240
Study 35710124 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided internet based cognitive behavioural therapy (CBT‐TF) with an eight step online programme, up to three hours of contact with a therapist, and four brief telephone calls or email contacts between sessions.
Number of subjects: 196
Study 35710124 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided internet based cognitive behavioural therapy (CBT‐TF)
Number of subjects: 196
Study 35710124 — intervention group
Group type: COMPARATOR
Intervention: Individual face‐to‐face cognitive behavioural therapy (CBT‐TF)
Number of subjects: 196
Study 32313779 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision and primary closure (Group A, n=30)
Number of subjects: 60
Study 32313779 — intervention group
Group type: COMPARATOR
Intervention: Bascom's technique (Group B, n=30)
Number of subjects: 60
Study 36462425 — intervention group
Group type: EXPERIMENTAL
Intervention: Classrooms with more classmates experiencing early childhood health shocks
Number of subjects: 0
Study 36462425 — intervention group
Group type: COMPARATOR
Intervention: Classrooms with fewer classmates experiencing early childhood health shocks
Number of subjects: 0
Study 34936159 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional lecture classroom
Number of subjects: 36
Study 34936159 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application
Number of subjects: 36
Study 34936159 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of traditional lecture and mobile application
Number of subjects: 36
Study 35576534 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate drink (CHO) group received 400 mL of a carbohydrate drink 2 to 3 hours before anesthesia
Number of subjects: 56
Study 35576534 — intervention group
Group type: COMPARATOR
Intervention: Control group allowed clear fluid intake 2 hours before anesthesia
Number of subjects: 56
Study 35576534 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate drink (CHO) group
Number of subjects: 56
Study 35576534 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 34041713 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra rapid lispro (URLi)
Number of subjects: 190
Study 34041713 — intervention group
Group type: COMPARATOR
Intervention: Humalog®
Number of subjects: 190
Study 34919684 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro+SM (specifically tailored multistrain probiotic powder and micronutrient mixture)
Number of subjects: 60
Study 34919684 — intervention group
Group type: COMPARATOR
Intervention: Con+BM (control treatment consisting of placebo and basic care micronutrient mixture)
Number of subjects: 60
Study 32894558 — intervention group
Group type: EXPERIMENTAL
Intervention: Myo-inositol (2 g), Alpha-Lactalbumin (50 mg), folic acid (200 µg) every morning for 6 months; Myo-inositol (600 mg), melatonin (1 mg), folic acid (200 µg) in the evening for 3 months before oocyte pick up; Myo-inositol (600 mg), folic acid (200 µg), melatonin (1 mg), vitamin D3 (50 µg) until the 12th week of gestation
Number of subjects: 100
Study 32894558 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with 200 µg folic acid twice a day
Number of subjects: 100
Study 32894558 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 32894558 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group
Number of subjects: 100
Study 35659181 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbosacral plexus block (LSPB) in the supine position
Number of subjects: 126
Study 35659181 — intervention group
Group type: COMPARATOR
Intervention: Lumbosacral plexus block (LSPB) in the lateral position
Number of subjects: 126
Study 36145188 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzobiotic therapy (synbiotics and proteolytic enzymes) over 12 weeks
Number of subjects: 85
Study 36145188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 33187502 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-peer instructor training
Number of subjects: 213
Study 33187502 — intervention group
Group type: COMPARATOR
Intervention: Expert instructor training
Number of subjects: 213
Study 35265960 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 g whole dragon fruit powder (33 mg betalains)
Number of subjects: 19
Study 35265960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 34593453 — intervention group
Group type: EXPERIMENTAL
Intervention: Sense of coherence (SOC) assessed using the SOC-13 questionnaire at 3-year follow-up
Number of subjects: 406
Study 34593453 — intervention group
Group type: EXPERIMENTAL
Intervention: Sense of coherence (SOC) assessed using the SOC-13 questionnaire at 5-year follow-up
Number of subjects: 406
Study 32811539 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed human albumin substitution aimed at a concentration > 30 g/l during surgery and postanesthesia care unit stay.
Number of subjects: 0
Study 32811539 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical care (Control group).
Number of subjects: 0
Study 34958693 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 4-hexylresorcinol (4-HR) and niacinamide
Number of subjects: 0
Study 34958693 — intervention group
Group type: COMPARATOR
Intervention: Niacinamide alone
Number of subjects: 0
Study 33482797 — intervention group
Group type: EXPERIMENTAL
Intervention: 980-nm diode laser
Number of subjects: 30
Study 33482797 — intervention group
Group type: COMPARATOR
Intervention: Control group (5 ml of 2.5% sodium hypochlorite, followed by 5 ml of 17% EDTA and 5 ml of distilled water)
Number of subjects: 30
Study 35965169 — intervention group
Group type: EXPERIMENTAL
Intervention: Remotely-administered resilience- and wisdom-focused intervention (6 once-a-week one-hour sessions)
Number of subjects: 20
Study 33164834 — intervention group
Group type: EXPERIMENTAL
Intervention: External Fixation (EF)
Number of subjects: 129
Study 33164834 — intervention group
Group type: COMPARATOR
Intervention: Intramedullary Nailing (IMN)
Number of subjects: 129
Study 33164834 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 129
Study 32341295 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy femtosecond laser pretreatment
Number of subjects: 40
Study 32341295 — intervention group
Group type: COMPARATOR
Intervention: Conventional phacoemulsification (control)
Number of subjects: 40
Study 32282520 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced flat times to 2 hours for venous and 4 hours for arterial
Number of subjects: 119
Study 35306660 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant dextrin (10 g day‐1 for 8 weeks)
Number of subjects: 76
Study 616782991 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine pattern-based clinical nursing care
Number of subjects: 160
Study 616782991 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing care
Number of subjects: 160
Study 35753560 — intervention group
Group type: EXPERIMENTAL
Intervention: MBSR
Number of subjects: 99
Study 35753560 — intervention group
Group type: EXPERIMENTAL
Intervention: MBSR-B
Number of subjects: 99
Study 35753560 — intervention group
Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 99
Study 33637348 — intervention group
Group type: EXPERIMENTAL
Intervention: VB-111 and weekly paclitaxel 80 mg/m2
Number of subjects: 60
Study 33637348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33637348 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment fever
Number of subjects: 60
Study 32726528 — intervention group
Group type: EXPERIMENTAL
Intervention: Nirsevimab (50 mg, single intramuscular injection)
Number of subjects: 1453
Study 32726528 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1453
Study 34880671 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion during intraoperative period and 72 postoperative hours
Number of subjects: 260
Study 34880671 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion at the same volume, infusion rate, and timing
Number of subjects: 260
Study 35955118 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES to supraspinatus and posterior deltoid muscles
Number of subjects: 28
Study 35955118 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 28
Study 33885958 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning–based denoising algorithm (DLA)
Number of subjects: 100
Study 33885958 — intervention group
Group type: COMPARATOR
Intervention: Filtered Back Projection (FBP)
Number of subjects: 100
Study 33885958 — intervention group
Group type: COMPARATOR
Intervention: ADMIRE
Number of subjects: 100
Study 32279451 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (0.9 mg/day)
Number of subjects: 64
Study 32279451 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin (10 mg/day)
Number of subjects: 64
Study 32279451 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 64
Study 32279451 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin
Number of subjects: 64
Study 32279451 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide and Empagliflozin
Number of subjects: 64
Study 34773928 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE)
Number of subjects: 81
Study 34773928 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioral relapse prevention therapy (RP)
Number of subjects: 81
Study 32280057 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical step sign (CSS)
Number of subjects: 6
Study 32280057 — intervention group
Group type: EXPERIMENTAL
Intervention: Diameter difference sign (DDS)
Number of subjects: 6
Study 32280057 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically relevant maltorsion (CRM)
Number of subjects: 6
Study 35670134 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective Tissue Graft (CTG)
Number of subjects: 50
Study 35670134 — intervention group
Group type: COMPARATOR
Intervention: Xenogeneic Acellular Dermal Matrix (XDM)
Number of subjects: 50
Study 33720541 — intervention group
Group type: EXPERIMENTAL
Intervention: Treat-and-extend (T&E) regimen
Number of subjects: 0
Study 33720541 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed bimonthly (FBM) regimen
Number of subjects: 0
Study 33720541 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro re nata (PRN) regimen
Number of subjects: 0
Study 33720541 — intervention group
Group type: EXPERIMENTAL
Intervention: Subretinal fluid (SRF)
Number of subjects: 0
Study 33720541 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraretinal fluid (IRF)
Number of subjects: 0
Study 33021196 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-lens reflex (SLR) photo-grading
Number of subjects: 412
Study 33021196 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone photo-grading
Number of subjects: 412
Study 33021196 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-CelScope device
Number of subjects: 412
Study 33021196 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone images with a simple attachment
Number of subjects: 412
Study 35576879 — intervention group
Group type: EXPERIMENTAL
Intervention: CDSS (PERI-KOAG)
Number of subjects: 168
Study 35576879 — intervention group
Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 168
Study 36085294 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD-rich cannabis treatment for 6 months
Number of subjects: 82
Study 35971232 — intervention group
Group type: EXPERIMENTAL
Intervention: Prune juice
Number of subjects: 0
Study 35971232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34655431 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (0.5 units IV bolus, adjusted by 0.25 units)
Number of subjects: 53
Study 32561877 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercise program (PEP)
Number of subjects: 236
Study 32561877 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 236
Study 34815548 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga for 6 weeks (n=14)
Number of subjects: 29
Study 32102810 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculotomy
Number of subjects: 248
Study 32102810 — intervention group
Group type: COMPARATOR
Intervention: Combined trabeculotomy-trabeculectomy (CTT)
Number of subjects: 248
Study 32102810 — intervention group
Group type: COMPARATOR
Intervention: CTT
Number of subjects: 248
Study 33527740 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid comprehensive telerehabilitation (HCTR)
Number of subjects: 850
Study 33527740 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 850
Study 32068189 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and problem-solving adherence intervention (8 sessions over 4 months)
Number of subjects: 200
Study 34332363 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Management (SM)
Number of subjects: 126
Study 34332363 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Restructuring (CR)
Number of subjects: 126
Study 32249112 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose of ready-to-use therapeutic foods (RUTF)
Number of subjects: 801
Study 32249112 — intervention group
Group type: COMPARATOR
Intervention: Reduced dose of ready-to-use therapeutic foods (RUTF)
Number of subjects: 801
Study 32249112 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (Standard and Reduced dose of RUTF)
Number of subjects: 801
Study 32249112 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard and Reduced dose of RUTF
Number of subjects: 801
Study 36036648 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control (ERC) therapy
Number of subjects: 0
Study 36036648 — intervention group
Group type: COMPARATOR
Intervention: AF ablation
Number of subjects: 0
Study 33742603 — intervention group
Group type: EXPERIMENTAL
Intervention: 650 mg of decaffeinated green tea extract (dGTE) for 4 weeks
Number of subjects: 8
Study 33742603 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA) for 4 weeks
Number of subjects: 8
Study 33853415 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline concussion testing before the RoCKAS‐ST
Number of subjects: 229
Study 33853415 — intervention group
Group type: COMPARATOR
Intervention: Baseline concussion testing after the RoCKAS‐ST
Number of subjects: 229
Study 36214084 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitators of healthy dietary behaviour
Number of subjects: 30
Study 36214084 — intervention group
Group type: EXPERIMENTAL
Intervention: External facilitators
Number of subjects: 30
Study 36214084 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal barriers
Number of subjects: 30
Study 36214084 — intervention group
Group type: EXPERIMENTAL
Intervention: External barriers
Number of subjects: 30
Study 33578583 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital practice group (n=12)
Number of subjects: 24
Study 33578583 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=12)
Number of subjects: 24
Study 32173478 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended current (Endocut Q)
Number of subjects: 928
Study 32173478 — intervention group
Group type: COMPARATOR
Intervention: Forced coagulation current (Erbe Inc)
Number of subjects: 928
Study 35277204 — intervention group
Group type: EXPERIMENTAL
Intervention: Indapamide
Number of subjects: 6119
Study 35277204 — intervention group
Group type: COMPARATOR
Intervention: Bendroflumethiazide
Number of subjects: 6119
Study 33068157 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 (360 µg daily for 6 months)
Number of subjects: 68
Study 33068157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 33369020 — intervention group
Group type: EXPERIMENTAL
Intervention: PRT + ProD (whey protein 20 g each morning plus 20 g postexercise and vitamin D3 2000 IU/day)
Number of subjects: 198
Study 33369020 — intervention group
Group type: COMPARATOR
Intervention: PRT (no supplementation)
Number of subjects: 198
Study 34217789 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical irradiation
Number of subjects: 102
Study 34217789 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial irradiation
Number of subjects: 102
Study 34217789 — intervention group
Group type: COMPARATOR
Intervention: No irradiation
Number of subjects: 102
Study 34217789 — intervention group
Group type: EXPERIMENTAL
Intervention: Any irradiation (radical or partial)
Number of subjects: 102